NovoCure LimitedNVCRNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-6.01%
↓ 129% below average
Average (9y)
20.81%
Historical baseline
Range
High:67.09%
Low:-8.11%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -6.01% |
| 2023 | 8.24% |
| 2022 | 2.38% |
| 2021 | 52.49% |
| 2020 | 67.09% |
| 2019 | 56.21% |
| 2018 | 32.73% |
| 2017 | -8.11% |
| 2016 | -5.21% |
| 2015 | 8.34% |